login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Trillium Therapeutic (TRIL) Stock News
NASDAQ:TRIL - Nasdaq -
18.44
+0.47 (+2.62%)
After market: 18.47
+0.03 (+0.16%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TRIL Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
TSLA
ENVB
CYBN
30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond
2 years ago - By: Benzinga
- Mentions:
BWVI
ENVB
Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
4 years ago - By: InvestorPlace
- Mentions:
AAPL
TGT
GOOG
NVDA
...
7 of the Best Stocks to Buy for Their Free Cash Flow
4 years ago - By: Trillium Therapeutics Inc.
- Mentions:
TRIL.CA
Trillium Therapeutics Receives Final Court Order Approving Arrangement
4 years ago - By: Trillium Therapeutics Inc.
- Mentions:
TRIL.CA
Trillium Securityholders Approve Acquisition by Pfizer
4 years ago - By: Monteverde & Associates PC
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Trillium Therapeutics, Inc. - TRIL
4 years ago - By: The Motley Fool
- Mentions:
CRIS
PFE
Why Curis Stock Perked Up in August
4 years ago - By: The Motley Fool
- Mentions:
PFE
Why Investors Should Love Pfizer's Acquisition of Trillium
4 years ago - By: Barron's
- Mentions:
BLUE
ACAD
ABCL
SRPT
...
Biotech Is Due for a Comeback. 5 Stocks That Could Lead a Revival.
4 years ago - By: Investor's Business Daily
- Mentions:
PANW
CRWD
CRM
SNOW
...
Stock Market Rally Hits Highs, Fed Chief Powell Backs Bond Taper; Palo Alto, CrowdStrike, Williams-Sonoma, Dick's Sporting Goods In Focus: Weekly Review
4 years ago - By: Zacks Investment Research
- Mentions:
JNJ
PFE
MRNA
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
4 years ago - By: StockMarket.com
- Mentions:
PFE
BPTH
OCGN
CARA
...
Top Health Care Stocks To Invest In Now? 5 For Your Late 2021 Watchlist
4 years ago - By: Halper Sadeh LLP
Trillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TRIL
4 years ago - By: Kahn Swick & Foti, LLC
TRILLIUM THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trillium Therapeutics Inc. - TRIL
4 years ago - By: InvestorPlace
- Mentions:
PFE
NVDA
BABA
4 Top Stock Trades for Tuesday: PFE, MRNA, NVDA, BABA
4 years ago - By: WeissLaw LLP
- Mentions:
PFE
SHAREHOLDER ALERT: WeissLaw LLP Investigates Trillium Therapeutics Inc.
Please enable JavaScript to continue using this application.
